A1AZ7

Nystatin

Created:	2024-07-29
Last modified:	2025-01-29

Find Related PDB Entry
1 entries where A1AZ7 is found as a standalone ligand

Help Find related ligands:
Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Help

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	140
Chiral Atom Count	19
Bond Count	142
Aromatic Bond Count	0

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	Nystatin
Synonyms	(1S,3R,4R,7R,9R,11R,15S,16R,17R,18S,19E,21E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy]-1,3,4,7,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,25,27,29,31-hexaene-36-carboxylic acid
Systematic Name (OpenEye OEToolkits)	(1~{S},3~{R},4~{R},7~{R},9~{R},11~{R},15~{S},16~{R},17~{R},18~{S},19~{E},21~{E},25~{E},27~{E},29~{E},31~{E},33~{R},35~{S},36~{R},37~{S})-33-[(2~{R},3~{S},4~{S},5~{S},6~{R})-4-azanyl-6-methyl-3,5-bis(oxidanyl)oxan-2-yl]oxy-15,16,18-trimethyl-1,3,4,7,9,11,17,37-octakis(oxidanyl)-13-oxidanylidene-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,25,27,29,31-hexaene-36-carboxylic acid
Formula	C₄₇ H₇₅ N O₁₇
Molecular Weight	926.095
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C(O)C1C(O)CC2(O)CC(O)C(O)CCC(O)CC(O)CC(O)CC(=O)OC(C)C(C)C(O)C(C)C=CC=CCCC=CC=CC=CC=CC(OC3OC(C)C(O)C(N)C3O)CC1O2
SMILES	CACTVS	3.385	C[CH]1OC(=O)C[CH](O)C[CH](O)C[CH](O)CC[CH](O)[CH](O)C[C]2(O)C[CH](O)[CH]([CH](C[CH](O[CH]3O[CH](C)[CH](O)[CH](N)[CH]3O)C=CC=CC=CC=CCCC=CC=C[CH](C)[CH](O)[CH]1C)O2)C(O)=O
SMILES	OpenEye OEToolkits	2.0.7	CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O
Canonical SMILES	CACTVS	3.385	C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@]2(O)C[C@H](O)[C@H]([C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@H]1C)O2)C(O)=O
Canonical SMILES	OpenEye OEToolkits	2.0.7	C[C@H]1/C=C/C=C/CC/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H]([C@@H](CC[C@H](C[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O
InChI	InChI	1.06	InChI=1S/C47H75NO17/c1-27-17-15-13-11-9-7-5-6-8-10-12-14-16-18-34(64-46-44(58)41(48)43(57)30(4)63-46)24-38-40(45(59)60)37(54)26-47(61,65-38)25-36(53)35(52)20-19-31(49)21-32(50)22-33(51)23-39(55)62-29(3)28(2)42(27)56/h5-6,8,10-18,27-38,40-44,46,49-54,56-58,61H,7,9,19-26,48H2,1-4H3,(H,59,60)/b6-5+,10-8+,13-11+,14-12+,17-15+,18-16+/t27-,28-,29-,30+,31+,32+,33+,34-,35+,36+,37-,38-,40+,41-,42+,43+,44-,46-,47+/m0/s1
InChIKey	InChI	1.06	VQOXZBDYSJBXMA-NQTDYLQESA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB00646
Name	Nystatin
Groups	investigational vet_approved approved
Description	Nystatin is a polyene antifungal drug that has broad-spectrum fungicidal and fungistatic activity against a number of yeasts and fungi, most notably _Candida_ species.[L10686] It is one of the most effective antifungal agents synthesized by bacteria, in this case a strain of _Streptomyces noursei_,[L10776] and is closely related to [amphotericin B], differing only slightly in structure.[A188562] Nystatin has a greater antifungal activity than amphotericin B - parenterally administered nystatin, however, is associated with significant toxicity and is not available in a formulation appropriate for systemic use.[A188562] As it undergoes very little absorption following oral or topical administration, nystatin's efficacy is limited to the treatment/prevention of cutaneous, mucocutaneous, and gastrointestinal fungal infections.[L10686,L10728]
Synonyms	NYS Nystatinum Nystatine Nystatin Nistatina Nystatin dihydrate
Brand Names	Flagystatin Mycostatin Oral Suspension 100000iu Kenacomb Mild Ointment Nystatin Nystatin Topical Powder Dom-nystatin Suspension Klayesta FIRST Dukes Mouthwash Compounding Mycostatin Crm 100000unit/gm Candistatin Topical Powder - 100000 Unit/g Theraderm Cream Nadostine Ont 100000iu/gm Nilstat Top Ont 100000unit/gm Nystatin Oral Suspension Ratio-nystatin Viaderm Kc Crm Mecomb Crm 0.1% Mycostatin Vaginal Crm 25000unit Nilstat Orl Tab 500000unit Nilstat Vag Tab 100000unit Nystatin and Triamcinolone Acetonide Mestatin Pedi-Dri Lidecomb Cream Nyata Nystatin Powder Mycostatin Ont 100000iu/gm Nyamyc Nystatin Cream PMS-nystatin Suspension 100000 Unit/ml Nyaderm Ont 100000unit/gm Kenacomb Mild Cream Jamp-nystatin Oral Suspension USP Mycostatin Oral Tab 500000iu FIRST Marys Mouthwash Compounding Teva-triacomb Nyaderm Oral Sus 100000unit/ml USP FIRST BXN Mouthwash Nilstat Top Crm 100000unit/gm Nilstat Sucrose-free Nyata Nadostine Tab 500000unit Nadostine Tab 100000unit Mycolog-II Viaderm Kc Ont Nilstat 25000units/g Nystatin and Triamcinolone Nadostine Crm 100000iu/gm Nystop Kenacomb Ont Kenacomb Ointment Teva-nystatin Nilstat Vag Crm 100000unit/gm Nadostine Sus 100000iu/ml Nystatin and triamcinolone acetonide Mycostatin Pediaderm AF PHL-nystatin Suspension 100000 Unit/ml Nyaderm Kenacomb Cream Ftp-nystatin Mycostatin Topical Pwr 100,000units/gm Nilstat Oral Dps 100000iu/ml
Indication	Nystatin is available in oral formulations for the treatment and/or prevention of oral candidiasis (a.k.a. thrush), intestinal candidiasis, and anal candidiasis.[L10686,L10728] It is indicated topically for the treatment of vulvovaginal candidiasis and other cutaneous candida infections.[L10728] A combination product containing nystatin alongside [neomycin], [gramicidin D], and [triamcinolone] (Viaderm K.C.®) is indicated in the treatment of corticosteroid-responsive dermatoses caused by bacterial or candidal infections and for pruritus ani/vulvae.[L10731] It is also available in combination with [metronidazole] for the treatment of mixed infections due to _Trichomonas vaginalis_ and _Candida albicans_.[L10776] Nystatin is also sometimes used off-label for the prevention of invasive candidiasis in low birth weight neonates,[A188565] though it is generally reserved as a second-line option after [fluconazole].
Categories	Alimentary Tract and Metabolism Anti-Infective Agents Antibacterials for Systemic Use Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents Antifungal Agents Antifungal Agents (Vaginal) Antifungals for Dermatological Use Antifungals for Topical Use Antiinfectives for Systemic Use Compounds used in a research, industrial, or household setting Dermatologicals Genito Urinary System and Sex Hormones Gynecological Antiinfectives and Antiseptics Intestinal Antiinfectives Ionophores Lactones Membrane Transport Modulators OATP1B1/SLCO1B1 Inhibitors OATP1B3 inhibitors Polyene Antifungal Polyenes Polyketides
ATC-Code	J01RA19 D01AA01 G01AA01 A07AA02 G01AA51
CAS number	1400-61-9

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

Name	Target Sequence	Pharmacological Action	Actions
Ergosterol	-	unknown	binder
Solute carrier organic anion transporter family member 1B1	MDQNQHLNKTAEAQPSENKKTRYCNGLKMFLAALSLSFIAKTLGAIIMKS...	unknown	inhibitor
Solute carrier organic anion transporter family member 1B3	MDQHQHLNKTAESASSEKKKTRRCNGFKMFLAALSFSYIAKALGGIIMKI...	unknown	inhibitor

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682